Quick Summary
Lacimto Tablet
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹39
MRP: ₹43.12
(You Save ₹4.12)
10 TABLET(s) IN A STRIP
10% OFF
₹39
MRP: ₹43.12
Inclusive of all taxes
10% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Phostat 667mg Tablet
ZYDUS CADILA
₹ 3.10/tablet
20% cheaper
Septacal Tablet
SEPTALYST LIFES...
₹ 3.90/tablet
0% cheaper
Lanum 667mg Tablet
LA RENON HEALTH...
₹ 4.20/tablet
8% costlier
Zerofos 667mg Tablet
ALNICHE LIFE SC...
₹ 4.20/tablet
8% costlier
Introduction
Lacimto Tablet contains Calcium acetate as its active ingredient. It is primarily prescribed to manage hyperphosphatemia, a condition marked by elevated phosphate levels in the blood, commonly seen in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing dialysis. By binding to dietary phosphate in the digestive tract, it helps reduce phosphate absorption, improving bone health and lowering the risk of bone pain, fractures, and skeletal complications.
Lacimto Tablet uses and benefits include reducing phosphate buildup, supporting bone strength, and minimizing the risk of cardiovascular issues such as blood vessel calcification. It can also relieve symptoms like itching and skin irritation often associated with kidney disease.
Patients often ask, “What is Lacimto Tablet used for?” — it is mainly prescribed to control phosphate levels as part of a broader kidney care plan, often alongside dietary modifications.
Possible Lacimto Tablet side effects may include nausea, constipation, or stomach discomfort. Always use this medication under medical supervision and report any allergic reactions or unusual symptoms immediately.
The Lacimto Tablet price may vary depending on brand and availability. Always consult your healthcare provider before starting or changing any phosphate binder medication.
Uses
The Lacimto Tablet is used in the treatment of the following:
-
Hyperphosphatemia in CKD/ESRD
-
Adjunct to dietary management in CKD/ESRD dialysis.
How Lacimto Tablet works
Lacimto Tablet's therapeutic action is its ability to bind with dietary phosphate in the gastrointestinal tract. Upon ingestion, it dissociates into calcium and acetate ions. The calcium ions form insoluble complexes with phosphate ions from ingested foods, forming calcium phosphate salts that are not absorbed into the bloodstream. As a result, phosphate absorption from the diet is reduced, leading to lower phosphate levels in the blood.
Interaction of Lacimto Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Lacimto Tablet 15's, reducing effectiveness by causing undesirable side effects.
Storage conditions
-
Should be stored at room temperature, between 20°C to 25°C.
-
Keep away from moisture, heat, and light.
-
It should not be frozen.
-
Keep away from children and pets.
How to take Lacimto Tablet
Lacimto Tablet is typically administered orally, meaning it is taken by mouth as tablets or capsules. The medication is designed to be swallowed with water and should not be chewed or crushed unless specifically instructed by a healthcare provider. The oral route is the most common and effective way to use this medication to manage hyperphosphatemia in individuals with chronic kidney and end-stage renal disease.
Safety Advices
Pregnancy
Pregnant women should consult their healthcare provider before taking Lacimto Tablets as its safety is not well studied in pregnant women.
Breast Feeding
Lacimto Tablets' safety during breastfeeding is not well established. Consult a healthcare provider before using this medication while breastfeeding.
Lungs
If you have lung conditions, it is advisable to consult your healthcare provider before using Lacimto Tablets.
Liver
Individuals with liver disease should consult a doctor regarding using Lacimto Tablets with their healthcare provider, as there may be considerations related to calcium and phosphate metabolism.
Alcohol
It is unsafe to use alcohol with Lacimto Tablet as interaction can cause certain side effects and also reduces the efficacy of this medication. If you experience dizziness or nausea, it is unsafe to take Lacimto Tablet with alcohol.
Driving
If you are experiencing side effects that could affect your ability to drive or operate machinery safely, taking a Lacimto Tablet while driving is unsafe.
Side Effects
Lacimto Tablet cause some side effects like all medications, although not everyone will experience them.
Serious side effects of Lacimto Tablet are:
-
Hypercalcemia
-
Calcium-based tissue deposition
-
Aluminum toxicity
Common side effects of Lacimto Tablet are:
-
Upset stomach
-
Constipation
-
Abdominal pain
-
Loss of appetite
-
Itching
-
Hypocalcemia.
Expert Tips
-
Inform your healthcare provider about your complete medical history, allergies, and any ongoing medications or supplements before starting treatment to ensure safe use.
-
Regular monitoring of blood phosphate levels is essential to evaluate the effectiveness of Lacimto Tablet in managing hyperphosphatemia.
-
Follow the dietary recommendations provided by your healthcare provider to enhance the medication’s effectiveness.
-
Watch for symptoms of electrolyte imbalance, such as:
-
Hypercalcemia: nausea, vomiting, and confusion.
-
Hypocalcemia: muscle cramps, tingling, or weakness.
-
Consult your doctor immediately if you experience any adverse effects — your physician may adjust your dosage or suggest an alternative treatment.
-
Pregnant and breastfeeding individuals should seek medical advice before using this medication.
-
Discuss any allergies, past hypersensitivity reactions, or underlying liver or lung conditions with your healthcare provider before starting therapy.
-
Always consult your healthcare provider for personalized advice and safe, effective use of this medicine based on your specific health needs.
FAQs
Q1.
What should I do if I miss a dose of Lacimto Tablet?
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up on doses.
Q2.
When does the Lacimto Tablet start working?
The time it takes for the Lacimto Tablet to start lowering phosphate levels can vary. Your healthcare provider will monitor your blood levels and adjust the treatment plan as needed to achieve the desired results.
Q3.
What should I do if I experience adverse effects from the Lacimto Tablet?
If you experience any adverse effects while taking Lacimto Tablet, contact your healthcare provider. They can assess the situation, provide guidance, and adjust your treatment plan if necessary.
Q4.
When should blood monitoring be done while using Lacimto Tablet?
The frequency of blood tests will be determined by your healthcare provider. Regular monitoring is important to ensure that calcium and phosphate levels are within the appropriate range.
Q5.
Are there any long-term effects of using the Lacimto Tablet?
Long-term use of Lacimto Tablet may lead to calcium-based tissue deposition and other complications. Regular monitoring and follow-up with your healthcare provider can help manage potential long-term effects.
Q6.
Can Lacimto Tablet lead to vitamin deficiencies?
Lacimto Tablet's primary impact is on phosphate and calcium levels. However, it's important to discuss your nutritional needs and possible vitamin deficiencies with your healthcare provider.
Fact Box
|
Molecule name |
Calcium acetate |
|
Therapeutic class |
Phosphate Binder |
|
Pharmacological class |
Calcium Salt, Phosphate Binder |
|
Indications |
1. Hyperphosphatemia in CKD/ESRD 2. Adjunct to dietary management in CKD/ESRD dialysis |
References
1. RenaCare NephroMed GmbH, Electronic Medicines Compendium (EMC), [Revised on Feb 2012] [Accessed on 22 August 2023], https://www.medicines.org.uk/emc/files/pil.4646.pdf
2. Genzyme Ireland Ltd, US Food and Drug Administration, [Revised on: 04/2020 ] [Accessed on 23rd August 2023] ,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022127s019,022318s021lbl.pdf
3. J. Goddard, A.N. Turner, Kidney and Urinary Tract Disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 461-523.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vikas B S
Pharm D
Reviewed By
Dr. Abhishaanth Prabu
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)
Want to know more?
Read Our Editorial Policy